Biosimilars: Benefits, Policies and Opportunities

  • June 08, 2021
  • 1:00 PM – 2:00 PM ET
  • Online

Biosimilars have the potential to lower health care costs and improve access to potentially life-changing therapeutics for the patient populations you serve. However, the development process, efficacy, and policy landscape for biosimilars are often misunderstood.

The webinar that will clarify the facts about biosimilars while providing insight into the future of this rapidly evolving space and how stakeholders will be affected.

Attendees will learn about:

  • The current and future state of biosimilar adoption and coverage in the United States
  • The biosimilar approval pathway and most recent biosimilar approvals
  • Interchangeability and substitution
  • Biosimilar spending and savings potential
  • The impact of federal and state biosimilar policies and trends to watch


Mary Jo Carden, RPh, JD
Head of Policy
Sandoz, Inc. (a Division of Novartis)

Mary Jo Carden serves as Head of Policy at Sandoz and previously served as Vice President of Government and Pharmacy Affairs at AMCP. She has also served as Director of Regulatory Affairs at Medco Health Solutions, in various government affairs capacities at the American Society of Consultant Pharmacists, and practiced as a retail pharmacist.

For more than 20 years Mary Jo has provided expertise and contributed to policy issues in the areas of Medicare Part D and B, Medicaid, the Affordable Care Act, Food and Drug Administration issues, and state policy issues.

Brian Lehman, RPh, MBA, MHA
Director, Patient Advocacy and Strategic Alliances
Sandoz, Inc. (a Division of Novartis)

Brian Lehman serves as Director, Patient Advocacy and Strategic Alliances at Sandoz Inc. He has 20 years of pharmacy plan management and retail pharmacy management experience, including activities in specialty drug management, influencing pharmaceutical policy and regulations, advocating for biosimilars, consulting and teaching.

Prior to joining Sandoz, Brian held several pharmacy management roles across various organizations, including manager of public policy at Humana, manager of the prescription drug program and policy at the Ohio Public Employees Retirement System, director of pharmacy benefits at the Ohio State University (OSU) Health Plan, and pharmacy team leader at Target Pharmacy.

Brian has served as a clinical assistant professor at the OSU College of Pharmacy and is currently serving as an adjunct professor. He holds a Bachelor of Science degree in Pharmacy from Ohio State University, a Master of Business Administration from Franklin University and a Master of Health Administration from OSU.